Amide aldehyde dehydrogenase agonists, methods of synthesis and uses thereof
By developing amide-based aldehyde dehydrogenase agonists to enhance ALDH2 activity, the pharmacokinetic problems of existing small molecule agonists have been solved, enabling effective treatment of acute alcohol poisoning and various health conditions.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-19
- Publication Date
- 2026-06-26
AI Technical Summary
Existing ALDH2 small molecule agonists suffer from pharmacokinetic problems such as poor water solubility, low activity, and short half-life, which hinder their clinical application. Furthermore, carriers of low-activity ALDH2 variants face a high risk of oxidative stress-related diseases, including cardiovascular and cerebrovascular diseases, diabetes, and neurodegenerative diseases.
A class of amide-based aldehyde dehydrogenase agonists has been developed, specifically consisting of a compound of formula I and its stereoisomers, pharmaceutically acceptable salts, hydrates, or solvates, to enhance the expression or activity of ALDH2, administered via intramuscular, intravenous, subcutaneous, or oral routes, for the treatment of diseases or symptoms associated with aldehyde dehydrogenase 2 activity.
It enhances the activity of ALDH2, reduces the accumulation of acetaldehyde in the body, and prevents damage to the human body caused by acetaldehyde. It has potential clinical application value and can fundamentally treat acute alcohol poisoning and prevent various health diseases.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Citation Information
Patent Citations
Modulators of aldehyde dehydrogenase activity and methods of use thereof
CN102209541A